Jun Ren

Jun has a multidisciplinary background and deep expertise in CAR T-cell therapy, immuno-oncology, and tumor microenvironment. Prior to joining Raqia, he worked at Massachusetts General Hospital and Harvard Medical School, where he developed multiple therapeutic strategies overcoming resistance to cancer immunotherapy and provided mechanistic insights in support of clinical trials. Jun received his Ph.D. from the University of Wisconsin-Madison, followed by postdoctoral training at Massachusetts General Hospital.